Infections and ischemic stroke outcome

Neurology Research International

Volumn 2011, Issue , 2011, Pages

  Grabska, Katarzyna ^a   Gromadzka, Grazyna ^a,b   Członkowska, Anna ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867518055     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2011/691348     Document Type: Article

References (33)

1. C. Weimar, M. P. Roth, G. Zillessen et al., "Complications following acute ischemic stroke," European Neurology, vol. 48, no. 3, pp. 133-140, 2002. (Pubitemid 35316817)
2. H. C. A. Emsley and S. J. Hopkins, "Acute ischaemic stroke and infection: recent and emerging concepts," The Lancet Neurology, vol. 7, no. 4, pp. 341-353, 2008. (Pubitemid 351380535)
3. P. J. Lindsberg and A. J. Grau, "Inflammation and infections as risk factors for ischemic stroke," Stroke, vol. 34, no. 10, pp. 2518-2532, 2003. (Pubitemid 37221976)
4. M. S. V. Elkind, J. M. Luna, Y. P. Moon et al., "Infectious burden and carotid plaque thickness. The Northern Manhattan Study," Stroke, vol. 41, no. 3, pp. e117-e122, 2010.
5. L. Smeeth, S. L. Thomas, A. J. Hall, R. Hubbard, P. Farrington, and P. Vallance, "Risk ofmyocardial infarction and stroke after acute infection or vaccination," The New England Journal of Medicine, vol. 351, no. 25, pp. 2611-2618, 2004. (Pubitemid 39628582)
6. P. Nencini, C. Sarti, R. Innocenti, G. Pracucci, and D. Inzitari, "Acute inflammatory events and ischemic stroke subtypes," Cerebrovascular Diseases, vol. 15, no. 3, pp. 215-221, 2003. (Pubitemid 36351209)
7. B. Tarnacka, G. Gromadzka, and A. Cz?onkowska, "Increased circulating immune complexes in acute stroke. The triggering role of Chlamydia pneumoniae and Cytomegalovirus," Stroke, vol. 33, no. 4, pp. 936-940, 2002. (Pubitemid 34293571)
8. J. S?owik, M. A. Wnuk, and K. Grzech, "Periodontitis affects neurological deficit in acute stroke," Journal of the Neurological Sciences, vol. 297, no. 1-2, pp. 82-84, 2010.
9. R. Martino, N. Foley, S. Bhogal, N. Diamant, M. Speechley, and R. Teasell, "Dysphagia after stroke. Incidence, diagnosis, and pulmonary complications," Stroke, vol. 36, no. 12, pp. 2756-2763, 2005.
10. M. Paciaroni, G. Mazzotta, F. Corea et al., "Dysphagia following stroke," European Neurology, vol. 51, no. 3, pp. 162-167, 2004. (Pubitemid 38608317)
11. P. Welsh, M. Barber, P. Langhorne, A. Rumley, G. D. O. Lowe, and D. J. Stott, "Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke," Cerebrovascular Diseases, vol. 27, no. 3, pp. 247-253, 2009.
12. S. Aslanyan, C. J. Weir,H. C.Diener, M. Kaste, K. R. Lees, and GAIN International Steering Committee and Investigators, "Pneumonia and urinary tract infection after acute ischaemic stroke: A tertiary analysis of the GAIN International trial," European Journal of Neurology, vol. 11, no. 1, pp. 49-53, 2004. (Pubitemid 38174922)
13. J. Kwan and P. Hand, "Infection after acute stroke is associated with poor short-term outcome," Acta Neurologica Scandinavica, vol. 115, no. 5, pp. 331-338, 2007. (Pubitemid 46699431)
14. F. H. Vermeij, W. J. M. S. O. Reimer, P. D. Man et al., "Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey," Cerebrovascular Diseases, vol. 27, no. 5, pp. 465-471, 2009.
15. Y. Lampl, M. Boaz, R. Gilad et al., "Minocycline treatment in acute stroke: an open-label, evaluator-blinded study," Neurology, vol. 69, no. 14, pp. 1404-1410, 2007. (Pubitemid 47511461)
16. S. Schwarz, F. Al-Shajlawi, C. Sick, S. Meairs, and M. G. Hennerici, "Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke," Stroke, vol. 39, no. 4, pp. 1220-1227, 2008. (Pubitemid 351440694)
17. A. Chamorro, J. P. Horcajada, V. Obach et al., "The early systemic prophylaxis of infection after stroke study. A randomized clinical trial," Stroke, vol. 36, no. 7, pp. 1495-1500, 2005. (Pubitemid 40967519)
18. D. van de Beek, E. F. M. Wijdicks, F. H. Vermeij et al., "Preventive antibiotics for infections in acute stroke. A systematic review and meta-analysis," Archives of Neurology, vol. 66, no. 9, pp. 1076-1081, 2009.
19. H. C. A. Emsley and P. J. Tyrrell, "Inflammation and infection in clinical stroke," Journal of Cerebral Blood Flow and Metabolism, vol. 22, no. 12, pp. 1399-1419, 2002. (Pubitemid 35424925)
20. World Health Organization (WHO), International Classification of Impairments, Disabilities and Handicaps, World Health Organization, Geneva, Switzerland, 1980.
21. M. A. Foulkes, P. A. Wolf, T. R. Price, J. P. Mohr, and D. B. Hier, "The Stroke Data Bank: design, methods, and baseline characteristics," Stroke, vol. 19, no. 5, pp. 547-554, 1988.
22. Scandinavian Stroke Study Group, "Multicenter trial of hemodilution in ischemic stroke-background and study," Stroke, vol. 16, no. 5, pp. 885-890, 1985.
23. J. C. van Swieten, P. J. Koudstaal, M. C. Visser,H. J. Schouten, and J. van Gijn, "Interobserver agreement for the assessment of handicap in stroke patients," Stroke, vol. 19, no. 5, pp. 604-607, 1988.
24. H. P. Adams Jr., B. H. Bendixen, L. J. Kappelle et al., "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment," Stroke, vol. 24, no. 1, pp. 35-41, 1993. (Pubitemid 23014379)
25. J. Bamford, P. Sandercock,M. Dennis, J. Burn, and C.Warlow, "Classification and natural history of clinical identifiable subtypes of cerebral infarction," The Lancet, vol. 337, no. 8756, pp. 1521-1526, 1991.
26. J. S. Garner, W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes, "CDC definitions for nosocomial infection," in APIC Infection Control and Applied Epidemiology: Principles and Practice, R. N. Olmsted, Ed., pp. A1-A20, Mosby, St. Louis, Mo,USA, 1996.
27. L. Roberts and C. Counsell, "Assessment of clinical outcomes in acute stroke trials," Stroke, vol. 29, no. 5, pp. 986-991, 1998. (Pubitemid 28228161)
28. T. Dziedzic, A. S?owik, and E. A. Gryz, "Lower serum triglyceride level is associated with increased stroke severity," Stroke, vol. 35, no. 6, pp. e151-e152, 2004.
29. R. Hilker, C. Poetter, N. Findeisen et al., "Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine," Stroke, vol. 34, no. 4, pp. 975-981, 2003. (Pubitemid 36402972)
30. A. Paganini-Hill, E. Lozano, G. Fischberg et al., "Infection and risk of ischemic stroke. Differences among stroke subtypes," Stroke, vol. 34, no. 2, pp. 452-457, 2003. (Pubitemid 36206347)
31. A. Hug, A. Dalpke, N. Wieczorek et al., "Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection," Stroke, vol. 40, no. 10, pp. 3226-3232, 2009.
32. J. Castillo, A. Dávalos, J. Marrugat, and M. Noya, "Timing for fever-related brain damage in acute ischemic stroke," Stroke, vol. 29, no. 12, pp. 2455-2460, 1998. (Pubitemid 28543989)
33. I. Y. Bova, N. M. Bornstein, and A. D. Korczyn, "Acute infection as a risk factor for ischemic stroke," Stroke, vol. 27, no. 12, pp. 2204-2206, 1996. (Pubitemid 26427193)